SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Fancy who wrote (5092)8/6/1998 4:44:00 PM
From: Peter Singleton  Read Replies (1) of 6136
 
Steve, I think the recent price action with AGPH was 100% market specific, and 0% AGPH specific.

If the market is correcting, then stabilizing or moving upward from here, then I think AGPH is about as cheap as you will see it, with the possibility of some nice upside surprises over the next 6-12 months, and probably quite a bit sooner.

If the market goes sharply south from here, then AGPH is at risk with the rest of the market ... however, at some point in a further market decline, AGPH may stop going down with the market since its price to value ratio are at such low levels now.

How's that for talking out of both sides of my mouth! I think we're at a high risk period for the market, and we'll have a good idea what's going to happen either way within a couple of months.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext